226 related articles for article (PubMed ID: 28429395)
1. ShRNA knock-down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Zhao ZW; Fan XX; Song JJ; Xu M; Chen MJ; Tu JF; Wu FZ; Zhang DK; Liu L; Chen L; Ying XH; Ji JS
J Cell Mol Med; 2017 Sep; 21(9):1989-1999. PubMed ID: 28429395
[TBL] [Abstract][Full Text] [Related]
2. [Effects of CXCR7-shRNA lentiviral vector on the growth and invasiveness of human hepatoma carcinoma cells in vitro].
Dai X; Xiong X; Wang L; Pan K; He L; Li H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):994-8. PubMed ID: 23895839
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Wnt/β-catenin signaling pathway on apoptosis, migration, and invasion of transplanted hepatocellular carcinoma cells after transcatheter arterial chemoembolization in rats.
Wang BM; Li N
J Cell Biochem; 2018 May; 119(5):4050-4060. PubMed ID: 29232009
[TBL] [Abstract][Full Text] [Related]
4. Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.
Zheng K; Li HY; Su XL; Wang XY; Tian T; Li F; Ren GS
J Exp Clin Cancer Res; 2010 Apr; 29(1):31. PubMed ID: 20380740
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
Zou Y; Guo CG; Zhang MM
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
[TBL] [Abstract][Full Text] [Related]
7. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
[TBL] [Abstract][Full Text] [Related]
10. ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells.
Gao W; Mei X; Wang J; Zhang X; Yuan Y
Tumour Biol; 2015 Sep; 36(9):7243-50. PubMed ID: 25894375
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma.
Lei HW; Huang BR; Cai J; Li CM; Shang CB; Liao ZY; Wan ZD
Kaohsiung J Med Sci; 2022 Aug; 38(8):781-789. PubMed ID: 35467082
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
15. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
Guo RP; Yu WS; Wei W
Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthase 3 affects invasion and metastasis of hepatocellular carcinoma via the
Cai J; Liu Y; Li Q; Wen Z; Li Y; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):588-599. PubMed ID: 35753729
[TBL] [Abstract][Full Text] [Related]
17. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
18. Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and β-arrestin pathways.
Li XX; Zheng HT; Huang LY; Shi DB; Peng JJ; Liang L; Cai SJ
Int J Oncol; 2014 Oct; 45(4):1649-57. PubMed ID: 25051350
[TBL] [Abstract][Full Text] [Related]
19. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
Xiong ZP; Yang SR; Xiao EH; Zhou SK; Zhang ZS; Liang ZY
Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):562-5. PubMed ID: 14690562
[TBL] [Abstract][Full Text] [Related]
20. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]